At the time of writing, Protara Therapeutics Inc [TARA] stock is trading at $2.01, up 5.24%. An important factor to consider is whether the stock is rising or falling in short-term value. The TARA shares have gain 10.44% over the last week, with a monthly amount glided 1.52%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Previously, H.C. Wainwright started tracking the stock with Buy rating on June 04, 2021, and set its price target to $40. On February 17, 2021, Oppenheimer initiated with a Outperform rating and assigned a price target of $43 on the stock. Cowen started tracking the stock assigning a Outperform rating and suggested a price target of $50 on October 19, 2020. Guggenheim initiated its recommendation with a Buy and recommended $50 as its price target on July 29, 2020.
For the past year, the stock price of Protara Therapeutics Inc fluctuated between $1.04 and $5.24. Protara Therapeutics Inc [NASDAQ: TARA] shares were valued at $2.01 at the most recent close of the market.
Analyzing the TARA fundamentals
Gross Profit Margin for this corporation currently stands at 0.69% with Operating Profit Margin at -36.63%, Pretax Profit Margin comes in at -33.68%, and Net Profit Margin reading is -33.68%. To continue investigating profitability, this company’s Return on Assets is posted at -0.4, Equity is -0.55 and Total Capital is -0.46. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.05.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 1.8600 points at the first support level, and at 1.7000 for the second support level. However, for the 1st resistance point, the stock is sitting at 2.1800, and for the 2nd resistance point, it is at 2.3400.
Ratios To Look Out For
It is important to note that Protara Therapeutics Inc [NASDAQ:TARA] has a current ratio of 16.33. On the other hand, the Quick Ratio is 16.33, and the Cash Ratio is 15.86.
Transactions by insiders
Recent insider trading involved Opaleye Management Inc., 10% Owner, that happened on Sep 12 ’24 when 0.13 million shares were sold. 10% Owner, Opaleye Management Inc. completed a deal on Sep 11 ’24 to sell 32600.0 shares. Meanwhile, 10% Owner Opaleye Management Inc. sold 36492.0 shares on Sep 09 ’24.
